Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Sleep Deprivation and Its Contribution to Mood and Performance Deterioration in College Athletes.

Bolin DJ.

Curr Sports Med Rep. 2019 Aug;18(8):305-310. doi: 10.1249/JSR.0000000000000621.

PMID:
31389873
2.

Ulcerative, granulomatous glossitis and enteritis caused by Rhodococcus equi in a heifer.

Saied AA, Bryan LK, Bolin DC.

J Vet Diagn Invest. 2019 Sep;31(5):783-787. doi: 10.1177/1040638719867120. Epub 2019 Jul 26.

PMID:
31347467
3.

Postmortem examination (2016-2017) of weanling and older horses for the presence of select species of endoparasites: Gasterophilus spp., Anoplocephala spp. and Strongylus spp. in specific anatomical sites.

Lyons ET, Bolin DC, Bryant UK, Cassone LM, Jackson CB, Janes JG, Kennedy LA, Loynachan AT, Boll KR, Burkhardt AS, Langlois EL, Minnis SM, Welsh SC, Scare JA.

Vet Parasitol Reg Stud Reports. 2018 Aug;13:98-104. doi: 10.1016/j.vprsr.2018.01.004. Epub 2018 Jan 12.

PMID:
31014896
4.

Fatal bromethalin intoxication in 3 cats and 2 dogs with minimal or no histologic central nervous system spongiform change.

Romano MC, Loynachan AT, Bolin DC, Bryant UK, Kennedy L, Filigenzi MS, Puschner B, Poppenga RH, Gaskill CL.

J Vet Diagn Invest. 2018 Jul;30(4):642-645. doi: 10.1177/1040638718775463. Epub 2018 May 2.

5.

A three-dimensional statistical model for imaged microstructures of porous polymer films.

Barman S, Bolin D.

J Microsc. 2018 Mar;269(3):247-258. doi: 10.1111/jmi.12623. Epub 2017 Sep 8.

PMID:
28884819
6.

Fast Bayesian whole-brain fMRI analysis with spatial 3D priors.

Sidén P, Eklund A, Bolin D, Villani M.

Neuroimage. 2017 Feb 1;146:211-225. doi: 10.1016/j.neuroimage.2016.11.040. Epub 2016 Nov 19.

7.

Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors.

de Vicente J, Tivitmahaisoon P, Berry P, Bolin DR, Carvajal D, He W, Huang KS, Janson C, Liang L, Lukacs C, Petersen A, Qian H, Yi L, Zhuang Y, Hermann JC.

ACS Med Chem Lett. 2015 Aug 4;6(9):1019-24. doi: 10.1021/acsmedchemlett.5b00251. eCollection 2015 Sep 10.

8.

National Athletic Trainers' Association position statement: Preparticipation physical examinations and disqualifying conditions.

Conley KM, Bolin DJ, Carek PJ, Konin JG, Neal TL, Violette D.

J Athl Train. 2014 Jan-Feb;49(1):102-20. doi: 10.4085/1062-6050-48.6.05. Review. Erratum in: J Athl Train. 2014 Mar-Apr;49(2):284.

9.

Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators.

Qian Y, Bolin D, Conde-Knape K, Gillespie P, Hayden S, Huang KS, Olivier AR, Sato T, Xiang Q, Yun W, Zhang X.

Bioorg Med Chem Lett. 2013 May 15;23(10):2936-40. doi: 10.1016/j.bmcl.2013.03.049. Epub 2013 Mar 22.

PMID:
23582275
10.

Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.

Yun W, Ahmad M, Chen Y, Gillespie P, Conde-Knape K, Kazmer S, Li S, Qian Y, Taub R, Wertheimer SJ, Whittard T, Bolin D.

Bioorg Med Chem Lett. 2011 Dec 1;21(23):7205-9. doi: 10.1016/j.bmcl.2011.09.039. Epub 2011 Sep 22.

PMID:
22001092
11.

Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors.

Qian Y, Ahmad M, Chen S, Gillespie P, Le N, Mennona F, Mischke S, So SS, Wang H, Burghardt C, Tannu S, Conde-Knape K, Kochan J, Bolin D.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6264-9. doi: 10.1016/j.bmcl.2011.09.009. Epub 2011 Sep 10.

PMID:
21958546
12.

Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.

Qian Y, Wertheimer SJ, Ahmad M, Cheung AW, Firooznia F, Hamilton MM, Hayden S, Li S, Marcopulos N, McDermott L, Tan J, Yun W, Guo L, Pamidimukkala A, Chen Y, Huang KS, Ramsey GB, Whittard T, Conde-Knape K, Taub R, Rondinone CM, Tilley J, Bolin D.

J Med Chem. 2011 Apr 14;54(7):2433-46. doi: 10.1021/jm101580m. Epub 2011 Mar 17.

PMID:
21413799
13.

Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors.

Tannu SA, Renzetti LM, Tare N, Ventre JD, Lavelle D, Lin TA, Morschauser A, Paciorek J, Bolin DR, Michel H, Singer L, Hargaden M, Knowles I, Gardiner P, Cazzola M, Calzetta L, Matera MG, Hicks A.

Br J Pharmacol. 2010 Nov;161(6):1329-42. doi: 10.1111/j.1476-5381.2010.00975.x.

14.

The application of osteopathic treatments to pediatric sports injuries.

Bolin DJ.

Pediatr Clin North Am. 2010 Jun;57(3):775-94. doi: 10.1016/j.pcl.2010.02.002. Review.

PMID:
20538156
15.

Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.

Allen GP, Bolin DC, Bryant U, Carter CN, Giles RC, Harrison LR, Hong CB, Jackson CB, Poonacha K, Wharton R, Williams NM.

Equine Vet J. 2008 Mar;40(2):105-10.

PMID:
18089469
16.

Equine multinodular pulmonary fibrosis: a newly recognized herpesvirus-associated fibrotic lung disease.

Williams KJ, Maes R, Del Piero F, Lim A, Wise A, Bolin DC, Caswell J, Jackson C, Robinson NE, Derksen F, Scott MA, Uhal BD, Li X, Youssef SA, Bolin SR.

Vet Pathol. 2007 Nov;44(6):849-62.

PMID:
18039898
17.

Accidental intra-auricular artery injection of ceftiofur in two beef steers.

Bolin DC.

J Vet Diagn Invest. 2007 Jan;19(1):125-8.

PMID:
17459848
18.

Three equine cases of mixed hepatoblastoma with teratoid features.

Loynachan AT, Bolin DC, Hong CB, Poonacha KB.

Vet Pathol. 2007 Mar;44(2):211-4.

PMID:
17317799
19.

Classification of Actinobacillus spp isolates from horses involved in mare reproductive loss syndrome.

Donahue JM, Sells SF, Bolin DC.

Am J Vet Res. 2006 Aug;67(8):1426-32.

PMID:
16881857
20.

Current concepts in the evaluation and management of stress fractures.

Bolin D, Kemper A, Brolinson PG.

Curr Sports Med Rep. 2005 Dec;4(6):295-300. Review.

PMID:
16282029
21.

Sideline documentation and its role in return to sport.

Bolin D, Goforth M.

Clin J Sport Med. 2005 Nov;15(6):405-9.

PMID:
16278542
22.

Microbiologic and pathologic findings in an epidemic of equine pericarditis.

Bolin DC, Donahue JM, Vickers ML, Harrison L, Sells S, Giles RC, Hong CB, Poonacha KB, Roberts J, Sebastian MM, Swerczek TW, Tramontin R, Williams NM.

J Vet Diagn Invest. 2005 Jan;17(1):38-44.

PMID:
15690949
23.

Electric delivery. Generally well tolerated by patients, iontophoresis has many uses for the rehab clinician.

Bolin D, Goforth M.

Rehab Manag. 2004 Dec;17(10):18-21, 54. Review. No abstract available.

PMID:
15605889
24.

Overuse injuries in equestrian athletes.

Pugh TJ, Bolin D.

Curr Sports Med Rep. 2004 Dec;3(6):297-303. Review.

PMID:
15509470
25.

Equine abortion and premature birth associated with Cellulosimicrobium cellulans infection.

Bolin DC, Donahue JM, Vickers ML, Giles RC, Harrison L, Jackson C, Poonacha KB, Roberts JE, Sebastian MM, Sells SE, Tramontin R, Williams NM.

J Vet Diagn Invest. 2004 Jul;16(4):333-6.

PMID:
15305747
26.

Transdermal approaches to pain in sports injury management.

Bolin DJ.

Curr Sports Med Rep. 2003 Dec;2(6):303-9. Review.

PMID:
14583158
27.

Meningeal worm in a reintroduced elk population in Kentucky.

Larkin JL, Alexy KJ, Bolin DC, Maehr DS, Cox JJ, Wichrowski MW, Seward NW.

J Wildl Dis. 2003 Jul;39(3):588-92.

PMID:
14567220
28.

Oxazole- and imidazole-based Ser-Leu dipeptide mimetics in potent inhibitors of antigen presentation by MHC class II DR molecules.

Sarabu R, Bolin DR, Campbell R, Cooper JR, Cox D, Gaizband D, Makofske R, Nagy Z, Olson GL.

Drug Des Discov. 2002;18(1):3-7.

PMID:
12375630
29.

Evidence for transmission of Halicephalobus deletrix (H gingivalis) from dam to foal.

Wilkins PA, Wacholder S, Nolan TJ, Bolin DC, Hunt P, Bernard W, Acland H, Del Piero F.

J Vet Intern Med. 2001 Jul-Aug;15(4):412-7. No abstract available.

31.

Intoxication of sheep exposed to ozark milkweed (Asclepias viridis Walter).

Smith RA, Scharko P, Bolin D, Hong CB.

Vet Hum Toxicol. 2000 Dec;42(6):349-50.

PMID:
11111941
32.

Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures.

Bolin DR, Swain AL, Sarabu R, Berthel SJ, Gillespie P, Huby NJ, Makofske R, Orzechowski L, Perrotta A, Toth K, Cooper JP, Jiang N, Falcioni F, Campbell R, Cox D, Gaizband D, Belunis CJ, Vidovic D, Ito K, Crowther R, Kammlott U, Zhang X, Palermo R, Weber D, Guenot J, Nagy Z, Olson GL.

J Med Chem. 2000 Jun 1;43(11):2135-48.

PMID:
10841792
33.

Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules.

Falcioni F, Ito K, Vidovic D, Belunis C, Campbell R, Berthel SJ, Bolin DR, Gillespie PB, Huby N, Olson GL, Sarabu R, Guenot J, Madison V, Hammer J, Sinigaglia F, Steinmetz M, Nagy ZA.

Nat Biotechnol. 1999 Jun;17(6):562-7.

PMID:
10385320
34.

Binding affinity independent contribution of peptide length to the stability of peptide-HLA-DR complexes in live antigen presenting cells.

Siklodi B, Vogt AB, Kropshofer H, Falcioni F, Molina M, Bolin DR, Campbell R, Hämmerling GJ, Nagy ZA.

Hum Immunol. 1998 Aug;59(8):463-71.

PMID:
9712349
35.

Peptide dependence of major histocompatibility complex class II specific alloreactive responses.

Vidović D, Toral JI, Bolin DR, Ito K, Nagy ZA.

Scand J Immunol. 1998 Mar;47(3):191-4.

36.

Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.

Xia M, Sreedharan SP, Bolin DR, Gaufo GO, Goetzl EJ.

J Pharmacol Exp Ther. 1997 May;281(2):629-33.

PMID:
9152366
37.
38.

Influence of CD26 and integrins on the antigen sensitivity of human memory T cells.

Falcioni F, Shah H, Vidović D, Morimoto C, Belunis C, Bolin D, Nagy ZA.

Hum Immunol. 1996 Oct;50(2):79-90.

PMID:
8891731
40.

Induction of class II major histocompatibility complex blockade as well as T cell tolerance by peptides administered in soluble form.

Nihira SI, Falcioni F, Juretic A, Bolin D, Nagy ZA.

Eur J Immunol. 1996 Aug;26(8):1736-42.

PMID:
8765014
41.

Low-grade dermal angiosarcoma of the breast following radiotherapy.

Bolin DJ, Lukas GM.

Am Surg. 1996 Aug;62(8):668-72. Review.

PMID:
8712566
42.

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.

Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E, Belunis C, Bolin DR, Arceo R, Campbell R, Falcioni F, Vidović D, Hammer J, Nagy ZA.

J Exp Med. 1996 Jun 1;183(6):2635-44.

43.

Comparison of cyclic and linear analogs of vasoactive intestinal peptide.

Bolin DR, Cottrell J, Garippa R, Rinaldi N, Senda R, Simko B, O'Donnell M.

Drug Des Discov. 1996 Apr;13(3-4):107-14.

PMID:
8874048
44.

The effect of 6-aminonicotinamide on testicular development in the rat.

Bolin DC, Carlton WW.

Vet Hum Toxicol. 1996 Apr;38(2):85-8.

PMID:
8693691
45.

Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments.

Vidović D, Falcioni F, Siklodi B, Belunis CJ, Bolin DR, Ito K, Nagy ZA.

Eur J Immunol. 1995 Dec;25(12):3349-55.

PMID:
8566022
46.

Structure-activity studies on the vasoactive intestinal peptide pharmacophore. 1. Analogs of tyrosine.

Bolin DR, Cottrell J, Garippa R, Michalewsky J, Rinaldi N, Simko B, O'Donnell M.

Int J Pept Protein Res. 1995 Sep-Oct;46(3-4):279-89.

PMID:
8537181
47.

Self tolerance to T cell receptor V beta sequences.

Falcioni F, Vidović D, Ward ES, Bolin D, Singh G, Shah H, Ober B, Nagy ZA.

J Exp Med. 1995 Jul 1;182(1):249-54.

48.
49.

Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma.

Bolin DR, Michalewsky J, Wasserman MA, O'Donnell M.

Biopolymers. 1995;37(2):57-66. Review.

PMID:
7893947
50.

Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis.

O'Donnell M, Garippa RJ, Rinaldi N, Selig WM, Tocker JE, Tannu SA, Wasserman MA, Welton A, Bolin DR.

J Pharmacol Exp Ther. 1994 Sep;270(3):1289-94.

PMID:
7932181

Supplemental Content

Support Center